Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorOPADEYI, A. O.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorFOURRIER-REGLAT, Annie
dc.contributor.authorISAH, A. O.
dc.date.accessioned2020-12-14T08:58:31Z
dc.date.available2020-12-14T08:58:31Z
dc.date.issued2018-05-31
dc.identifier.issn2050-6511 (Electronic) 2050-6511 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/21422
dc.description.abstractEnBACKGROUND: WHO pharmacovigilance indicators have been recommended as a useful tool towards improving pharmacovigilance activities. Nigeria with a myriad of medicines related issues is encouraging the growth of pharmacovigilance at peripheral centres. This study evaluated the status of pharmacovigilance in tertiary hospitals in the South-South zone of Nigeria with a view towards improving the pharmacovigilance system in the zone. METHODS: A cross-sectional descriptive survey was conducted in six randomly selected tertiary hospitals in the South-South zone of the country. The data was collected using the WHO core pharmacovigilance indicators. The language of assessment was phrased and adapted in this study for use in a tertiary hospital setting. Data is presented quantitatively and qualitatively. RESULTS: A total of six hospitals were visited and all institutions had a pharmacovigilance centre, only three could however be described as functional or partially functional. Only one centre had a financial provision for pharmacovigilance activities. Of note was the absence of the national adverse drug reaction reporting form in one of the hospitals. The number of adverse drug reaction reports found in the databases of the centres ranged from none to 26 for the previous year and only one centre had fully committed their reports to the National Pharmacovigilance Centre. There were few documented medicines related admissions ranging from 0.0985/1000 to 1.67/1000 and poor documentation of pharmacovigilance activities characterised all centres. CONCLUSION: This study has shown an urgent need to strengthen the pharmacovigilance systems in the South-South zone of Nigeria. Improvement in medical record documentation as well as increased institutionalization of pharmacovigilance may be the first steps to improve pharmacovigilance activities in the tertiary hospitals.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enPharmacoEpi-Drugs
dc.title.enAssessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
dc.title.alternativeBMC Pharmacol Toxicolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1186/s40360-018-0217-2en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29855348en_US
bordeaux.journalBMC Pharmacology and Toxicologyen_US
bordeaux.page27en_US
bordeaux.volume19en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03164957
hal.version1
hal.date.transferred2021-03-10T11:13:04Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=BMC%20Pharmacology%20and%20Toxicology&rft.date=2018-05-31&rft.volume=19&rft.issue=1&rft.spage=27&rft.epage=27&rft.eissn=2050-6511%20(Electronic)%202050-6511%20(Linking)&rft.issn=2050-6511%20(Electronic)%202050-6511%20(Linking)&rft.au=OPADEYI,%20A.%20O.&FOURRIER-REGLAT,%20Annie&ISAH,%20A.%20O.&rft.genre=article


Fichier(s) constituant ce document

Thumbnail
Thumbnail

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée